Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Moderate to Severe Asthma: later-stage trial registry
3 of 4 indexed Moderate to Severe Asthma trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Moderate to Severe Asthma: 4 US clinical trials tracked, 3 recruiting.
Moderate to Severe Asthma is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Washington University School of Medicine, running 1 of these trials.
Enrollment posture brief
Registry condition moderate-to-severe-asthma
OPEN 3 | RECR 75% | LATE 2 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Moderate to Severe Asthma lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Moderate to Severe Asthma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Moderate to Severe Asthma is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma
Washington University School of Medicine
NCT07241117
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
Incyte Corporation
NCT05851443
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
University of California, San Diego
NCT06385236
Phase I Assessment of Hypertonic Saline in Moderate to Severe Asthmatics
University of North Carolina, Chapel Hill
NCT03556683
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Moderate to Severe Asthma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Moderate to Severe Asthma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Moderate to Severe Asthma page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Moderate to Severe Asthma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Washington University School of Medicine sponsors the most Moderate to Severe Asthma trials on record, review their full trial history before evaluating a specific study. See Washington University School of Medicine's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Moderate to Severe Asthma condition card totals 4 registered trials; most-linked intervention Salbutamol; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.